The city argued Ashley Overbey was exercising her First Amendment rights by agreeing to refrain from speech in exchange for money. However, the majority ruled that the First Amendment did not apply to her refraining from speech, because her ordered silence did not protect any of the interests at stake in the case.

Baltimore No Longer Able to Offer Police Brutality Settlements with Gag Orders

The Fourth Circuit Court has ruled 2-1 that settlement money cannot silence victims of police brutality in Baltimore, the Courthouse News Service reports.

The case began in 2012 when Baltimore resident Ashley Overbey accused three officers of beating her during a confrontation after she reported a burglary in her home. Overbey sued and ended up settling for $63,000. However, the settlement included a gag order which had a non-disparagement clause.

Related Story: Mayor Can’t Resist More Racist Blabber as Settlement is Reached in Cop Rage Incident

When the Baltimore Sun featured Overbey in a 2014 story about the city’s police brutality settlement cases, other publications outlined her story. Anonymous readers took to the comment sections of these articles to troll and make racist comments toward Overbey. She responded, defending herself. As a result, the city withheld half of her settlement money for violating the agreement’s non-disparagement clause.

Commenters accused Overbey of initiating the violence to score a settlement, and she replied, recounting the facts of the case. One of the officers accused Overbey of pushing him after engaging in a verbal confrontation, but Overbey accused the officer of aggressively barging into her apartment without announcing himself, pulling her hair and hitting her. Another officer joined and a third tased her. Overbey was charged with assault and resisting arrest but the city later dropped the charges.

The court took back $31,500 in response to Overbey engaging in the comments of these articles. She sued for the $31,500 and was dismissed. The Fourth Circuit reversed the decision on July 11. The two judges who agreed to reverse the earlier decision claimed the settlement’s gag order violated the First Amendment.

“We hold that the non-disparagement clause in Overbey’s settlement agreement amounts to a waiver of her First Amendment rights and that strong public interests rooted in the First Amendment make it unenforceable and void,” U.S. Circuit Judge Henry Floyd and Judge Stephanie Thacker wrote. Judge Marvin Quattlebaum dissented.

The city argued Overbey was exercising her First Amendment rights by agreeing to refrain from speech in exchange for money. However, the majority ruled that the First Amendment did not apply to her refraining from speech, because her ordered silence did not protect any of the interests at stake in the case.

Overbey is not the only person who Baltimore has awarded a settlement in the wake of a police brutality case. The Sun’s 2014 article stated the city had paid about $5.7 million in settlements since 2011. In 2017, it reported another four cases in which the city settled for a combined $1.1 million.

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on about.kaiserpermanente.org. Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands ShopOpenings.com to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on mastercardcontentexchange.com. Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….